EPIDERMAL GROWTH FACTOR RECEPTOR
Clinical trials for EPIDERMAL GROWTH FACTOR RECEPTOR explained in plain language.
Never miss a new study
Get alerted when new EPIDERMAL GROWTH FACTOR RECEPTOR trials appear
Sign up with your email to follow new studies for EPIDERMAL GROWTH FACTOR RECEPTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First patients to receive new cancer drug in groundbreaking safety trial
Disease control Recruiting nowThis is the first study in people to test a new drug called EPI-326. It aims to find a safe dose and see how the body handles the drug in patients with advanced lung cancer (with a specific genetic change) or advanced head and neck cancer. The main goal is to check for side effec…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Spinal injection offers hope for lung Cancer's worst brain complication
Disease control Recruiting nowThis study is testing a new combination treatment for a serious complication where lung cancer spreads to the lining of the brain and spinal cord. It involves injecting a chemotherapy drug directly into the spinal fluid, alongside a targeted oral medication, for patients whose pr…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE2 • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New approach aims to extend control of advanced lung cancer
Disease control Recruiting nowThis study is looking at whether adding surgery or radiation to the primary lung tumor can help people with advanced, EGFR-mutant lung cancer live longer without their cancer getting worse. It is for patients whose cancer has been controlled by a specific combination of drugs. Th…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE2 • Sponsor: Pusan National University Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Scientists test High-Tech scan to map aggressive brain cancer
Knowledge-focused Recruiting nowThis study aims to test a new combined MRI and PET scan technique to better see and measure the aggressive, energy-consuming parts of brain tumors called glioblastoma. Researchers will scan adults who are already scheduled for tumor removal surgery and compare the scan results wi…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Apr 04, 2026 03:21 UTC